News Daily News Etripamil Nasal Spray Gains FDA Approval for Acute Paroxysmal SVT Todd Neale December 15, 2025
News Conference News AHA 2024 Nasal Bumetanide Safe, Effective in Healthy Adults Yael L. Maxwell November 18, 2024
News Conference News AHA 2024 One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024 Shelley Wood November 14, 2024
Presentation TCT 2024 TCT 754: Native Coronary Artery Instead of Saphenous Vein Graft Intervention for Treatment of Significant Saphenous Vein Graft Lesions (“NASA” Registry) Presenter: Michaella Alexandrou October 30, 2024
Presentation TCT 2024 TCT 907: High Flow Nasal Oxygenation in Sedation for Transcatheter Aortic Valve Replacement Procedures, Results of a Randomized Controlled Trial: The HIGH-OXY-TAVR Study Presenter: Manel Sabate October 29, 2024
News Conference News AHA 2023 Etripamil Nasal Spray Shows Promise for AF Patients With Rapid Ventricular Rate Todd Neale November 16, 2023
News Daily News Etripamil Continues to Show Promise in Paroxysmal SVT: NODE-302 Caitlin E. Cox September 27, 2023
News Conference News AHA 2022 Etripamil Nasal Spray in Paroxysmal SVT Speeds Conversion to Sinus Rhythm: RAPID Shelley Wood November 07, 2022
News Daily News RAPID: Positive Top-line Results for Etripamil Nasal Spray in Paroxysmal SVT Todd Neale October 17, 2022
News Opinion Off Script Amid Civil War and COVID-19, Cardiology in Sudan Takes Courage and Hope Nafisa Elsammani, MBBS, MD April 26, 2022
News Daily News No Gravity, Smaller Hearts: LV Mass Declines in Space and Water Michael O'Riordan March 29, 2021
News Features The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive Todd Neale February 08, 2021